openPR Logo

Press Releases from Nanion Technologies (18 total)

Nanion Starts Shipping the SyncroPatch 384 Patch Engine - a Revolutionary Instru …

The brand-new SyncroPatch 384 Patch Engine (PE) now released by Nanion Technologies propels ion channel drug discovery to a new level. Designed for seamless integration into process-automated drug screening environments, the Patch Engine is equipped with 384 patch clamp amplifiers and an advanced 384 channel liquid handling robot. The SyncroPatch 384PE is the high quality, automated patch clamp system able to finally thrust gold standard electrophysiology from secondary to primary

Nanion Introduces New Product Family: CardioExcyte 96 for Cardiac Toxicity Profi …

Munich, Germany, September 12, 2013; The CardioExcyte 96 is a high resolution device recording contractility in intact cardiomyocyte networks utilizing non-invasive impedance measurements. The system allows cost-efficient, early compound safety profiling using stem cell-derived cardiomyocytes, freshly dissociated cardiomyocytes or beating 3D-cell clusters. Cardiac safety assessment is a vital part of drug development since late withdrawals of compound candidates, due to heart liability issues such as ventricular arrhythmia, are very

Nanion Introduces NPC-Certified Cell Lines

Munich, Germany, November 08, 2012; Nanion’s automated patch clamp platforms are known for their high cell compatibility, even for primary cells and stem cells. Nanion now introduces “Nanion Approved Cells”, where commercially available cell lines from several providers have been evaluated and certified based on cell and platform performance. The approved cells can be directly purchased through Nanion, so that Nanion’s customers get a complete package of APC platform and

Nanion Acquires the SURFE2R Technology for Transporter Protein Analysis

Nanion acquires the well-established SURFE2R technology, allowing state-of-the-art measurements of transporter protein activity and function. The SURFE2R technology is an excellent enhancement to Nanion’s existing products which until now covered ion channels and nanopores. Nanion Technologies is one of the leading providers of high quality automated patch clamp systems. Nanion’s efficient and versatile products drastically improve the data output in patch clamp-based ion channel screening, safety testing and scientific research. Since

Nanion Introduces the Orbit 16 – a Pioneering Device for Parallel Lipid Bilaye …

Munich, Germany, February 23, 2012; Today, Nanion announces the introduction of a completely new product line for efficient analysis of bilayer-reconstituted ion channels and nanopores. The first of these, the Orbit 16, allows for automated formation of, and recordings from 16 bilayers in parallel, combining efficient data generation and ultra-high data quality. The Orbit 16 takes the pain out of bilayer recordings and facilitates efficient data generation through 16

Nanion Celebrates Its 10th Anniversary - Still With A Strong Focus On New Innova …

Munich, Germany, January 15, 2012; Today, Nanion celebrates 10 years of innovation, scientific product development and successful roll-outs of several product families. Nanion is a success story of organic, revenue-based company growth and dedicated young professionals. 10 years ago, Nanion Technologies started out in a small loft at the Institute of Physiology of Ludwig-Maximilian’s University in Munich. Since then, Nanion has grown from 2 to 40 employees and has successfully

Nanion opens new branch in China

Nanion announces the opening of yet another branch. To meet the needs of the rapidly expanding number of customers in China, the dedicated sales- and support team in Beijing now opens the doors to Nanion Technologies China. Nanion successfully entered the Chinese market over five years ago, and the installed base of Patchliner and Port-a-Patch instruments has grown constantly ever since. To cover the increasing interest and activities within the

Nanion’s automated patch clamp platforms show unparalleled results using stem …

Munich, Germany, September 16, 2011; The Patchliner and the SyncroPatch 96 have successfully been used for compound analysis under current- and voltage clamp recording conditions using different stem cell-derived cardiomyocytes. The exceptional cell-platform-compatibility and the unique experimental possibilities offered by Nanion’s platforms open up whole new avenues for compound safety testing. Pluripotent stem cell-derived cardiomyocytes have tremendous potentials for cardiac safety and efficacy testing of drug candidates. By offering an

Nanion’s Patchliner exceptionally well received by academic ion channel core f …

Munich, Germany, March 4th, 2011; The new year has started well for Nanion; in the first weeks of 2011 more than five Patchliners were sold and shipped to academic institutions intended for advanced ion channel research and screening projects, and are soon to be followed by the first SyncroPatch 96 shipment and installation. The Patchliner, a highly versatile patch clamp screening platform for increased throughput, has been on the market since

Final success in Nanion’s opposition against Molecular Devices patent – “I …

Munich, Germany, April 15th, 2010; Nanion Technologies GmbH (Nanion), a supplier of automated, parallel patch-clamp systems based in Munich, Germany, today announced that a Board of Appeal of the European Patent Office (EPO) has overturned an earlier decision of the Opposition Division to uphold patent EP 1,040,349 owned by Molecular Devices, Inc. (MDC). The disputed patent was originally filed by the Ecole Polytechnique Federale in Lausanne, Switzerland and then taken over

Nanion is winner of the Deutscher Gruenderpreis 2009

Munich, Germany, June 30th, 2009; During the award ceremony in Berlin, Nanion was announced winner of the Deutscher Gründerpreis 2009. The Deutscher Gründerpreis is the most important award for outstanding entrepreneurs in Germany. The prize includes a coaching by Porsche Consulting and a mentorship for Nanion. The mentor for Nanion is Dr. Jürgen Heraeus, Chairman of the Supervisory Board of Heraeus Holding. The Deutscher Gründerpreis is the most important award

Nanion and Axiogenesis present parallel patch clamp recordings of action potenti …

Stem cell derived cardiomyocytes were analyzed using Nanion’s automated patch clamp systems, the Patchliner and the Port-a-Patch to validate ion channel composition, the presence of action potentials and the effect of compounds on cardiac ion channels. Stem cell derived cardiomyocytes have tremendous potential for cardiac safety testing of drug candidates. By offering an authentic cellular environment they are closer to the actual physiological situation compared to cell lines with over-expressed ion

Nanion opens US-office in New Jersey

Munich, Germany, February 17th, 2009: Nanion today announces the opening of Nanion Technologies Inc. with headquarters in North Brunswick, NJ, USA. To support the increasing demand of Nanion’s products, and to continue giving premium customer service, Nanion now expands its presence in the American market. Nanion opens the doors to the US-office in the “Heart of Pharma”, North Brunswick, NJ. Nanion Technologies Inc. has a fully equipped demonstration and service

Nanion nominated for The German Industry’s Innovation Award

Munich, Germany, Jan 20th, 2009; Nanion is again nominated for a prestigious innovation award, due its impressive product portfolio of automated patch clamp systems. More than 350 companies competed in this year’s Innovation Award and Nanion is finalist in the category “Start-Up Companies”. The German Industry’s Innovation Award, also the world’s first innovation award, has since 1980 annually nominated and rewarded the nation’s most important scientific and technical innovations. Nanion is

Nanion’s Port-a-Patch is used for bilayer research and education at the Techni …

Munich, Germany, Dec. 17th; Starting in 2008, Nanion’s Port-a-Patch is being used in education and research at the Institute for Biomolecular Systems and Bioelectronics, Department of Physics at the Technical University of Munich. Because of its ease of use and the high quality data generated, the Port-a-Patch is of great value in basic biophysical research and hands-on education of students. “The Port-a-Patch allows students and researchers with no prior experience in

Nanion increases throughput and cuts costs with a new industrial 96-channel patc …

Munich, Germany, November 18th, 2008; Today, Nanion announces the late-stage development of a new automated patch clamp platform: the SyncroPatch 96. Developed to meet the throughput demands of industrial ion channel drug screening and safety profiling, and with a price-per-data-point compatible with screening standards, the SyncroPatch 96 will offer the highest throughput in the market for high quality HTS-oriented ion channel screening. Following the successful market introduction of two automated patch

Nanion's Technology Nominated for Presidential Innovation Award

Munich, Oct 11, 2007: The planar patch clamp technology used in a family of automated electrophysiology products developed and marketed by Nanion Technologies GmbH in Munich, Germany, is among four technological and scientific innovations that have been nominated for this year's Deutscher Zukunftspreis (German Future Award). The nomination of the project "Small Holes – Big Effects: Cell Physiology in a Chip Format" represented by Nanion's CEO, Niels Fertig as

Automated internal perfusion with the Port-a-Patch

Nanion Technologies introduces the Internal Perfusion System for the Port-a-Patch; a completely unique device for rapid, continuous and automated exchange of internal solutions during patch clamp recordings. Using the internal perfusion system, ion channels regulated by internal binding sites for second messengers can be easily modulated or compounds acting on the internal side of the membrane like e.g. hERG active substances can be directly applied internally. Planar patch clamp chips offer the

Go To Page:   1 2 3 4 5 6 7 8 9 10